Arrowhead Pharmaceuticals, Inc. (ARWR)
ARWR price $58.69 -0.15 -0.25%
- Ticker
- ARWR
- Price
- $58.69
- Change
- -0.15 -0.25%
- Market cap
- $8.29B
- P/E
- -26.27
- Forward P/E
- 13.32
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 60
Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primarily leverages RNA interference (RNAi) technology. Among its advanced clinical programs are: ARO-AAT, a Phase II…